Condition: HIV-1 Infection · Sponsor: Henan Genuine Biotech Co., Ltd.
This study will evaluate the antiretroviral activity, safety and pharmacokinetics of single dose of CL-197 capsule in three dose groups administered to antiretroviral treatment-naïve adult participants with human immunodeficiency virus type 1 (HIV-1) infection.
This description comes directly from the study's public registry record.
Ping DU · 8618810261827 · pingdu2012@163.com
Tong Zhang · 8613601072376 · zt_doc@163.com
Always discuss trial participation with your own doctor first.
| Beijing Youan Hospital, Capital Medical University | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07308782